| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/10/2008 | CA2664119A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| 04/09/2008 | EP1908751A1 N-hydroxy benzamides with antitumour activity |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907382A1 Nitrocatechol derivatives as comt inhibitors |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907363A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907361A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907360A1 Improved process for the manufacture of flecainide |
| 04/09/2008 | EP1907120A1 Catalyst with bimodal distribution of the particles of the catalytically active material, method for the production thereof and for the regeneration thereof and the use of the catalyst |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1572651A4 Compounds useful as pesticides |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160288A Method for producing nicotinic acid derivative or its salt |
| 04/09/2008 | CN101160287A 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
| 04/09/2008 | CN101160285A Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 04/09/2008 | CN101157654A Preparation method of 2-chlorin-3-amido-4-methyl pyridine |
| 04/09/2008 | CN101157653A Method for preparing 2,6-diacetyl pyridine |
| 04/09/2008 | CN101157652A Antitumor activity bipyridine methyl amine compound and preparation method thereof |
| 04/09/2008 | CN100379725C Immunoassay detection method for neonicotinyl insecticides |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/08/2008 | US7355049 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 04/08/2008 | US7355048 Process for preparing 1-(6-methylpyridin-3-yl)-2-[4- (methylsulphonyl)phenyl]ethanone |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7354946 Biarylurea derivatives |
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008037604A1 Novel polybenzofulvene derivatives, synthesis and uses thereof |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | US20080081926 Sulfonylaminobenzoic acid and salt |
| 04/03/2008 | US20080081912 Near-infrared absorptive image-forming composition, ink and electrophotographic toner using the same, and inkjet-recording method, electrophotographic-recording method and near-infrared-ray-reading method using those |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/02/2008 | EP1905761A1 An improved process for the preparation of 4-[2-(methyl-2-pyridinylamino) ethoxy] benzaldehyde, an intermediate for the preparation of rosiglitazone |
| 04/02/2008 | EP1905438A2 Hypoglycemic agent |
| 04/02/2008 | EP1904537A1 Polymerisation catalyst system based on dioxime ligands |
| 04/02/2008 | EP1904471A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 04/02/2008 | EP1904439A2 Sphingosine kinase inhibitors |
| 04/02/2008 | EP1765771A4 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN101155782A Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 04/02/2008 | CN101155781A Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378076C Pyridine carboxamide derivatives and their use as pesticides |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100378072C Heterocyclic methyl sulfone derivative |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/02/2008 | CN100378059C Diastereoselective method of preparing olefins by means of the Horner-Wadsworth-Emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 04/01/2008 | US7351865 Synthesis of sterically hindered secondary aminoether alcohols from acid anhydride and/or acid halide and sulfur trioxide |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 04/01/2008 | US7351835 Organic molecular cataylst having binaphthol skeleton and processes for producing the same and application thereof |
| 04/01/2008 | US7351834 Sorafenib and salts such as tosylate (N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea); serine-threonine kinase inhibitor; antitumor and anticarcinogenic agent |
| 04/01/2008 | US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351733 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | CA2332713C Hydroxamic acid derivatives as antibacterials |
| 03/27/2008 | WO2008034886A1 Pyridine borane complexes |
| 03/27/2008 | WO2008034272A1 Stilbazolium salt |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | WO2007141200A8 Novel n-aryl and n-heteroaryl substituted pyridinone derivatives for use in mch-1 mediated diseases |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007134038A3 Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
| 03/27/2008 | WO2007132179A3 Therapeutics comprising pyridinium derivatives |
| 03/27/2008 | US20080076930 Novel stereoselective synthesis of benzimidazole sulfoxides |
| 03/27/2008 | US20080076805 Antagonists and/or inverse agonists of CB1; N'-[1-(3-chlorophenyl)-2-(4-chlorophenyl)ethyl]-N'-methyl-N-(2-methyl-2-[5-(trifluoromethylpyridin-2-yl)oxy]propanoyl)hydrazide for example; obesity, psychological disorders, analgesics, drug abuse, constipation, asthma, cirrhosis |
| 03/27/2008 | US20080076801 Indolylalkylpyridin-2-amines for the inhibition of beta-secretase |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076794 Hyperaldosteronism |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | DE102006043520A1 2-Phenoxynikotinsäure-Derivate und ihre Verwendung 2-Phenoxynikotinsäure derivatives and their use |
| 03/27/2008 | DE102006043519A1 4-Phenoxynikotinsäure-Derivate und ihre Verwendung 4-Phenoxynikotinsäure derivatives and their use |
| 03/27/2008 | CA2663901A1 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 03/27/2008 | CA2663677A1 Pyridine borane complexes |
| 03/26/2008 | EP1903030A1 Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
| 03/26/2008 | EP1903023A1 Method for manufacturing arylamines |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1902074A1 Single site catalyst systems having a scorpion-like structure |
| 03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
| 03/26/2008 | EP1902022A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 03/26/2008 | EP1902017A1 Antiviral compounds and methods |
| 03/26/2008 | EP1902004A2 Onium-alkylsulfonate production method |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |